Skip to main content
logo
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
35.81
+0.15 (0.42%)
Jan 7, 2026, 11:29 AM EST - Market open

Moderna Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product Sales
2.96B3.03B3.11B4.96B4.90B5.01B6.67B8.77B---
Product Sales Growth
-39.64%-39.56%-53.40%-43.42%-51.65%-65.15%-63.88%-57.23%---
Grant and Collaboration
120.00M149.00M145.00M191.00M200.00M-177.00M384.00M554.00M
Grant and Collaboration Growth
-40.00%-15.82%-62.24%-65.52%-72.26%--78.62%-56.31%-30.23%

Product Sales by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
1.58B1.66B1.73B2.28B1.98B1.82B1.72B1.94B
United States Growth
-20.01%-8.91%0.35%17.52%-1.69%-47.44%-60.95%-
Europe
--1.29B1.06B--1.35B2.96B3.90B5.23B6.73B
Europe Growth
---66.94%-79.78%---79.90%----
Rest of World
802.00M798.00M810.00M1.79B2.21B2.41B3.60B3.84B
Rest of World Growth
-63.63%-66.94%-77.49%-53.39%-47.31%-57.24%-50.70%-

Operating Expense Breakdown

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
3.82B4.34B4.54B4.83B4.85B4.78B4.85B4.65B
Research and Development Growth
-21.34%-9.23%-6.23%3.81%12.53%23.37%47.04%70.20%
Selling, General, and Administrative
1.07B1.11B1.17B1.29B1.45B1.52B1.55B1.45B
Selling, General, and Administrative Growth
-26.13%-26.75%-24.21%-11.07%12.71%29.85%36.84%51.77%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.